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ABSTRACT
Background In the context of widespread
opportunistic chlamydia screening among young adults,
we aimed to quantify chlamydia testing and diagnosis
among 16–24 year olds in Britain in relation to risk
factors for prevalent chlamydia infection.
Methods Using data from sexually experienced (≥1
lifetime sexual partner) 16-year-old to 24-year-old
participants in Britain’s third National Survey of Sexual
Attitudes and Lifestyles (conducted 2010–2012), we
explored socio-demographic and behavioural factors
associated with prevalent chlamydia infection (detected
in urine; n=1832), self-reported testing and self-reported
diagnosis in the last year (both n=3115).
Results Chlamydia prevalence was 3.1% (95% CI
2.2% to 4.3%) in women and 2.3% (1.5% to 3.4%) in
men. A total of 12.3% of women and 5.3% men had a
previous chlamydia diagnosis. Factors associated with
prevalent infection were also associated with testing and
diagnosis (eg, increasing numbers of sexual partners),
with some exceptions. For example, chlamydia
prevalence was higher in women living in more deprived
areas, whereas testing was not. In men, prevalence was
higher in 20–24 than 16–19 year olds but testing was
lower. Thirty per cent of women and 53.7% of men
with ≥2 new sexual partners in the last year had not
recently tested.
Conclusions In 2010–2012 in Britain, the proportion
of young adults reporting chlamydia testing was
generally higher in those reporting factors associated
with chlamydia. However, many of those with risk
factors had not been recently tested, leaving potential
for undiagnosed infections. Greater screening and
prevention efforts among individuals in deprived areas
and those reporting risk factors for chlamydia may
reduce undiagnosed prevalence and transmission.
INTRODUCTION
Chlamydia trachomatis (‘chlamydia’) is the most
commonly diagnosed sexually transmitted infection
(STI) in the UK.1 Most chlamydia infections are
asymptomatic, and untreated infections can cause
serious complications including pelvic inﬂamma-
tory disease, ectopic pregnancy and tubal factor
infertility in women.2 By diagnosing and treating
asymptomatic infections, chlamydia screening
potentially reduces the risk of complications3 and is
expected to reduce chlamydia prevalence and trans-
mission.4 In England, the National Chlamydia
Screening Programme (NCSP) recommends that
sexually active under 25 year olds are tested annu-
ally and on change of sexual partner.5 Chlamydia
screening is offered opportunistically in clinical and
non-clinical settings in England. Scotland and
Wales do not have an organised screening pro-
gramme; guidelines recommend asymptomatic
testing of young adults6–8 with a focus on those at
high risk (eg, those reporting multiple sexual part-
ners in the last year, those with a previous diagnosis
or patients attending genitourinary medicine
(GUM) clinics).
Chlamydia testing of young adults increased sub-
stantially in the UK over the last decade. Increases
in testing occurred in GUM clinics as a result of
improved access to sexual health services9–11 and
availability of diagnostic testing using non-invasive
samples.12 In England, a major increase was driven
by the national scale-up of the NCSP. After a
phased roll-out from 2003 to 2008, a step change
in screening activity outside of GUM clinics was
seen from 2008 to 2010 as local areas responded
to national targets for testing coverage.13 Testing
coverage (number of tests divided by total
15-year-old to 24-year-old population) peaked at
34% in 2010 and fell slightly to 30% and 26% in
2011 and 2012, respectively.14 15
The third National Survey of Sexual Attitudes
and Lifestyles (Natsal-3) is a stratiﬁed cross-
sectional probability sample survey of adults resi-
dent in Britain (England, Scotland and Wales;
Northern Ireland was not included).16 Conducted
from 2010 to 2012, Natsal-3 included anonymous
testing of urine specimens for STI, including chla-
mydia, and asked questions on chlamydia testing
and diagnosis history. The survey provides a unique
opportunity to investigate patterns of chlamydia
infection and testing within a nationally representa-
tive sample of the British population.
Sonnenberg et al previously reported an overview
of STI prevalence and service use using data from
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Natsal-3.17 Chlamydia prevalence in 16–44 year olds was 1.5%
in women and 1.1% in men and was higher among 16–24 year
olds (women: 3.1%; men: 2.3%). Among 16–24 year olds,
54.2% of women and 34.6% of men reported testing in the last
year. Although prevalence was reported by age group, factors
associated with prevalent infection were assessed among all 16–
44 year olds. Only a limited number of factors associated with
chlamydia prevalence and testing were explored (age group, area-
level deprivation, sexual partners in the last year, sexual partners
in the last year without a condom (investigated for prevalence
only), age at ﬁrst sex and any same-sex experience). In this paper,
we report a detailed analysis among 16–24 year olds in Britain as
this is the age group targeted by the NCSP in England. We
describe and compare factors associated with prevalent chlamydia
infection, previous chlamydia diagnosis and chlamydia testing to
assess the extent to which opportunistic chlamydia screening is
reaching young adults at risk of chlamydia.
METHODS
Participants and procedures
In Natsal-3, participants were interviewed using computer-
assisted face-to-face and computer-assisted self-interview for the
most sensitive questions. The overall response rate was 57.7%, in
line with other major social surveys conducted in Britain around
the same time,18 19 achieving a sample of 15 162 16–74 year
olds.16 A subset of participants, including all 16–17 year olds
(regardless of reported sexual activity) and 18–24 year olds who
reported at least one sexual partner by the time of the interview
(hereafter termed ‘sexually experienced’) were invited to provide
a urine sample for anonymous STI testing.16 17 Participants did
not receive their test results.20 Of all Natsal-3 respondents eligible
for the urine study, 57% provided a sample. Urine samples were
posted to Public Health England where they were batch-tested
for chlamydia using the Aptima Combo 2 assay (Hologic
Gen-Probe); positive and equivocal results were conﬁrmed with
the Aptima chlamydia monospeciﬁc assay.17 Details of the survey
methods and questionnaire are available elsewhere.16
We estimated the prevalence of chlamydia detected in urine
(hereafter termed ‘prevalent infection’), self-reported chlamydia
test in the last year (‘recent testing’), self-reported chlamydia
diagnosis in the last year (‘recent diagnosis’) and self-reported
chlamydia diagnosis ever.
A ﬂow chart of participants included in our analyses is pre-
sented in the online supplementary material. Analyses of recent
testing and recent diagnosis were based on sexually experienced
16–24 year olds (n=3115). Analyses of prevalent infection were
among those who provided a urine sample for STI testing and
for whom a valid chlamydia test result is available (n=1832, 62
of whom had a prevalent infection).
Statistical analyses
Analyses were carried out using Stata V.12.1, accounting for
weighting, clustering and stratiﬁcation of the data. Survey
weights were applied to adjust for unequal probability of selec-
tion and non-response to make the sample data broadly repre-
sentative of the British general population, according to the
2011 Census, in terms of sex, age group and Government
Ofﬁce Region.16 Willingness to provide a urine sample varied
by demographic and behavioural variables, including age,
number of sexual partners (by the time of the interview/without
a condom in the last year), same-sex experience and sexual
health clinic attendance. Estimates of prevalent infection were
therefore given an additional weight to reduce bias in the proﬁle
of urine sample respondents.16 21
Factors associated with prevalent infection, recent diagnosis
and recent testing were investigated using univariable and mul-
tivariable logistic regression, for women and men separately.
Although the overall percentage diagnosed with chlamydia
(ever or in the last year) was estimated among the sexually
experienced population, risk factors for recent diagnosis were
investigated among those with a recent test to investigate asso-
ciations with being infected at the time of testing rather than
with testing per se. Socio-demographic and behavioural factors
previously demonstrated to be associated with STI risk were
included as predictor variables.22–24 Associations with depriv-
ation were explored using both residence-based (quintile of
Index of Multiple Deprivation (IMD) for the lower layer super
output area (LSOA) of residence (a geographical area of
around 1500 people25)) and individual-based (age left school)
measures. Sexual behaviours investigated included numbers
of sexual partners in the last year (total, new, without a
condom), number of sexual partners by the time of the inter-
view (hereafter ‘lifetime sexual partners’) and condom use at
last sex. Frequency of binge drinking was included as a proxy
for sexual risk behaviour that may not be captured in reported
numbers of sexual partners.
With two exceptions, all variables included in univariable
models were included in multivariable models: number of
sexual partners in the last year was not included due to collin-
earity with other sexual partnership variables; age left school
was not included as data were unavailable for 16 year olds.
To explore how chlamydia infections were distributed across
population subgroups, we calculated the percentage reporting
selected socio-demographic and behavioural factors among (a)
individuals with a prevalent infection, (b) individuals recently
diagnosed and (c) the sexually experienced population.
RESULTS
Table 1 shows chlamydia prevalence and self-reported chla-
mydia testing and diagnosis in the last year among sexually
experienced 16–24 year olds. Around two-thirds (62.5%) of
women and 43.2% of men had either been tested or offered a
test in the last year. A total of 12.3% of women and 5.3% men
had ever been diagnosed with chlamydia.
Among those recently tested, <10% reported a clinical indica-
tion (symptoms; a partner with chlamydia/symptoms; check-up
after a previous diagnosis) for their last test. Around three-
quarters of women and half of men had last been tested in a
sexual health clinic, general practice (GP) surgery or family plan-
ning clinic. Almost all (95.4%) individuals recently diagnosed had
most recently been tested in one of these settings. Half of those
recently diagnosed had last been tested due to symptoms or
having a partner with chlamydia/symptoms (table 2).
Tables 3 and 4 explore the associations between socio-
demographic and behavioural variables and prevalent infection,
recent testing and recent diagnosis. In univariable analyses,
higher numbers of sexual partners (total/new/without a
condom) in the last year were signiﬁcantly (p<0.05) associated
with prevalent infection among women and men. In women,
area-level deprivation (measured at LSOA level) and frequency
of binge drinking were also associated with prevalent infection.
Among men, number of lifetime sexual partners, age group, age
left school, age at ﬁrst sex and condom non-use at last sex were
signiﬁcantly associated with prevalent infection. Similar factors
were associated with recent diagnosis among those tested. In
multivariable analyses, living in more deprived areas and more
frequent binge drinking remained signiﬁcantly associated with
having a prevalent infection in women. Older age group, living
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in more deprived areas and higher numbers of lifetime sexual
partners remained signiﬁcantly associated with prevalent infec-
tion in men.
Figure 1 shows unadjusted ORs for prevalent infection and
recent testing by socio-demographic and behavioural factors.
Groups in the upper right hand quadrant are those where both
the odds of prevalent infection and of testing were higher than
the reference group. Groups in the upper-left-hand quadrant had
higher odds of prevalent infection, but lower odds of testing than
the reference group. Factors associated with recent testing were
similar to those associated with prevalent infection, with some
exceptions. Whereas women living in one of the two most
deprived IMD quintiles had almost four times higher odds of
prevalent infection versus those living in less deprived areas (OR
3.82, 95% CI 1.35 to 10.79), the odds of recent testing did not
differ by deprivation (OR 0.99, 0.77 to 1.27). Among men, the
odds of prevalent infection were higher among 20–24 vs 16–
19 year olds (OR 10.6, 2.40 to 46.3), but odds of recent testing
were lower in the older age group (OR 0.67, 0.44 to 0.84). In
men, not having used a condom at last sex was associated with a
sixfold increase in the odds of prevalent infection (OR 6.03, 1.87
to 19.42), but was not associated with recent testing (OR 1.22,
0.95 to 1.56). Similar patterns were seen when comparing
adjusted ORs from multivariable models (tables 3 and 4).
Although the proportion recently tested was generally higher
in those reporting risk factors for chlamydia, recent testing
remained well below 100% in all socio-demographic and behav-
ioural subgroups. For example, 30.0% of women and 53.7% of
men with ≥2 new sexual partners in the last year and 25.8% of
women and 51.2% of men reporting ≥2 sexual partners
without a condom in the last year had not been recently tested
(tables 3 and 4).
Among individuals with a prevalent chlamydia infection, 14%
(95% CI 7% to 14%) had ever been diagnosed with chlamydia
and 5% (2% to 17%) reported a diagnosis in the last year
(indicating either repeat or persistent infections). Fifty per cent
(35–64%) of those with a prevalent infection reported a recent
chlamydia test (89% of whom did not report a recent diagnosis,
thus indicating incident infections within the last year). Over
two-thirds of prevalent infections were among individuals resi-
dent in one of the 40% most deprived LSOA. Infections in
women were more evenly distributed by numbers of sexual part-
ners than in men. For example, among men, 80% of those with
a prevalent infection and 77% of those recently diagnosed
reported ≥10 lifetime sexual partners versus only 25% of the
population. In women, 35% of those with a prevalent infection
reported ≥10 lifetime sexual partners versus 21% of the popula-
tion (see online supplementary table S1).
Table 2 Reason and location of most recent chlamydia test, among those tested for chlamydia in the last year, by sex and by whether
diagnosed in last year (sexually experienced 16–24 year olds)
By sex By whether diagnosed in the last year*
Women Men
Diagnosed in the last
year
Not diagnosed in
the last year
% 95% CI % 95% CI % 95% CI % 95% CI
Denominator (weighted, unweighted) 523, 943 347, 475 48, 81 816, 1330
Reason for most recent test
Had symptoms 4.2 3.0 to 5.8 4.2 2.7 to 6.5 29.0 19.0 to 41.5 2.7 1.9 to 3.8
Partner diagnosed with chlamydia or had symptoms 2.8 1.7 to 4.5 3.8 2.4 to 6.1 20.9 12.8 to 32.2 2.2 1.4 to 3.4
Check up after a previous positive 1.3 0.63 to 2.6 0.95 0.33 to 2.7 8.6 3.2 to 21.1 0.7 0.4 to 1.4
Wanted a check-up/offered a test/worried about risk 84.9 82.1 to 87.4 87.3 83.8 to 90.1 37.2 26.2 to 49.86 88.7 86.8 to 90.4
Other 6.8 5.3 to 8.7 3.7 2.3 to 6.0 4.3 1.5 to 12.0 5.7 4.5 to 7.1
Location of most recent chlamydia test
Sexual health clinic 28.9 25.5 to 32.6 30.5 25.9 to 35.5 62.9 50.4 to 73.9 27.6 25.0 to 30.4
GP surgery 35.1 31.7 to 38.6 17.0 13.6 to 20.9 27.1 17.7 to 39.1 28.0 25.3 to 30.8
NHS Family Planning clinic 9.2 7.4 to 11.4 4.3 2.7 to 6.8 5.4 1.6 to 16.3 7.3 6.0 to 8.9
School, college or university 11.6 9.4 to 14.2 24.5 20.4 to 29.1 1.7 0.4 to 7.2 17.5 15.2 to 20.1
Elsewhere 15.2 12.9 to 17.8 23.8 19.3 to 28.9 2.9 1.0 to 8.1 19.6 17.2 to 22.2
*Women and men were combined due to small denominator for diagnosed in the last year.
95% CI of unadjusted OR and p values for unadjusted and adjusted OR are presented in full in the online supplementary material.
GP, general practice; NHS, National Health Service.
Table 1 Prevalence of chlamydia infection detected in urine and of self-reported testing and diagnosis by sex (sexually experienced 16–24 year olds)
Women Men
Denominator*
(weighted, unweighted)
% 95% CI % 95% CI Women Men
Prevalent chlamydia infection detected in urine 3.1 2.2 to 4.3 2.3 1.5 to 3.4 597, 992 625, 840
Tested for chlamydia in the last year 54.2 51.4 to 56.9 34.6 31.9 to 37.4 966, 1736 1003, 1375
Offered, not tested for chlamydia in the last year 8.3 6.9 to 9.9 8.6 7.0 to 10.4 966, 1735 1001, 1373
Diagnosed with chlamydia in the last year 3.0 2.2 to 4.0 2.0 1.3 to 3.0 962, 1727 992, 1364
Ever diagnosed with chlamydia 12.3 10.6 to 14.1 5.3 4.1 to 6.7 962, 1727 992, 1364
*Denominators for recent testing/offer of testing and for diagnosis (recent or ever) differ due to item-missingness.
95% CI of unadjusted OR and p values for unadjusted and adjusted OR are presented in full in the online supplementary material.
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Table 3 Percentage, unadjusted and adjusted ORs for prevalent chlamydia infection, self-reported diagnosis in the last year and self-reported testing by socio-demographic and behavioural factors
(sexually experienced 16–24 year old women)
Prevalent infection detected in urine (n=992)
Diagnosed with chlamydia in the last year
(among those tested in the last year) (n=940) Tested for chlamydia in the last year (n=1736)
Denominator (weighted,
unweighted)*
% 95% CI OR AOR† 95% CI % 95% CI OR AOR† 95% CI % 95% CI OR AOR† 95% CI Infection Diagnosis Tested
Age group
16–19 3.8 2.2 to 6.3 1.00 1.00 – 6.0 3.8 to 9.2 1.00 1.00 – 56.6 52.5 to 60.6 1.00 1.00 – 214, 395 193, 375 343, 672
20–24 2.7 1.7 to 4.3 0.71 0.71 0.27 to 1.87 5.1 3.4 to 7.6 0.86 0.80 0.35 to 1.78 52.8 49.2 to 56.4 0.86 0.82 0.62 to 1.07 383, 597 329, 565 623, 1064
Country‡
England 2.9 2.0 to 4.3 1.00 1.00 – 57.1 54.1 to 60.1 1.00 1.00 – 504, 817 469, 832 823, 1452
Scotland 3.1 1.1 to 8.6 1.08 1.34 0.43 to 4.14 32.4 24.4 to 41.5 0.36 0.29 0.18 to 0.45 56, 103 30, 58 91, 178
Wales 5.3 1.9 to 13.8 1.87 1.88 0.63 to 5.54 45.6 36.2 to 55.4 0.63 0.53 0.32 to 0.85 37, 72 24, 50 52, 106
IMD quintile of LSOA of residence§
2 least deprived 1.3 0.5 to 3.4 1.00 1.00 – 4.8 2.8 to 8.1 1.00 1.00 – 54.2 49.5 to 58.8 1.00 1.00 – 213, 355 183, 319 338, 595
Middle quintile 1.8 0.8 to 4.2 1.37 1.40 0.39 to 4.98 3.5 1.6 to 7.3 0.71 1.06 0.37 to 3.04 54.4 48.0 to 60.7 1.01 1.03 0.71 to 1.48 111, 174 102, 176 189, 324
2 most deprived 4.9 3.3 to 7.3 3.82 4.23 1.53 to 11.6 6.8 4.6 to 10.0 1.46 1.70 0.73 to 3.91 54.0 49.8 to 58.2 0.99 0.97 0.73 to 1.29 273, 463 236, 445 439, 817
Age left school¶††
17+ 3.2 2.1 to 4.8 1.00 5.2 3.6 to 7.5 1.00 54.3 51.0 to 57.6 1.00 445, 700 387, 658 715, 1217
16 3.4 1.9 to 6.0 1.06 6.2 3.7 to 10.5 1.21 55.5 50.1 to 60.8 1.05 120, 229 109, 228 196, 405
Age at first heterosexual sex
17+ 1.6 0.7 to 3.7 1.00 1.00 – 4.1 1.8 to 8.9 1.00 1.00 – 43.9 38.7 to 49.1 1.00 1.00 – 188, 246 137, 215 313, 489
16 3.9 2.1 to 6.9 2.52 2.20 0.67 to 7.17 5.0 2.8 to 8.9 1.24 0.80 0.26 to 2.42 56.4 51.6 to 61.1 1.66 1.39 0.99 to 1.92 178, 304 154, 272 273, 503
<16 4.0 2.4 to 6.6 2.65 1.82 0.60 to 5.42 6.9 4.8 to 9.9 1.76 0.89 0.35 to 2.25 63.9 59.8 to 67.9 2.27 1.44 1.05 to 1.97 213, 415 220, 429 344, 680
Number of sexual partners in the last year††
0 or 1 2.5 1.5 to 4.0 1.00 3.0 1.7 to 5.4 1.00 46.6 43.3 to 50.0 1.00 387, 600 291, 507 624, 1096
2 3.9 1.8 to 8.5 1.62 6.6 3.7 to 11.6 2.25 65.2 58.8 to 71.1 2.15 90, 161 93, 178 143, 275
3–4 1.9 0.7 to 5.1 0.75 8.8 5.2 to 14.6 3.08 69.7 62.0 to 76.4 2.63 63, 127 76, 146 111, 210
5+ 8.3 3.9 to 16.8 3.57 11.6 6.2 to 20.8 4.19 74.8 64.4 to 83.0 3.40 49, 93 58, 101 77, 135
Number of new sexual partners in the last year
0 2.2 1.3 to 3.7 1.00 1.00 – 2.8 1.5 to 5.0 1.00 1.00 – 45.6 41.9 to 49.3 1.00 1.00 – 313, 495 226, 397 495, 873
1 2.8 1.2 to 6.3 1.26 1.17 0.38 to 3.52 4.8 2.5 to 9.1 1.76 1.89 0.69 to 5.16 59.2 54.0 to 64.2 1.73 1.69 1.25 to 2.27 160, 263 156, 287 264, 485
2+ 5.9 3.5 to 9.8 2.73 1.65 0.50 to 5.39 10.7 7.3 to 15.6 4.23 3.09 1.07 to 8.86 70.0 63.8 to 75.6 2.79 1.46 0.95 to 2.21 118, 225 137, 249 197, 359
Number of sexual partners in the last year without a condom
0 2.9 1.2 to 7.1 1.00 1.00 – 4.2 1.5 to 11.6 1.00 1.00 – 36.4 30.8 to 42.3 1.00 120, 173 76, 130 210, 361
1 2.2 1.4 to 3.6 0.76 0.34 0.10 to 1.10 3.8 2.4 to 6.1 0.90 0.72 0.15 to 3.21 54.7 51.4 to 58.0 2.11 1.52 1.03 to 2.24 368, 606 319, 567 585, 1049
2+ 6.3 3.5 to 11.2 2.25 0.49 0.12 to 1.83 10.3 7.0 to 15.0 2.60 0.90 0.18 to 4.49 74.2 68.3 to 79.4 5.04 1.86 1.09 to 3.15 108, 212 126, 241 169, 322
Number of lifetime sexual partners
1–4 2.4 1.4 to 4.2 1.00 1.00 – 2.1 1.1 to 4.0 1.00 1.00 – 43.5 40.0 to 47.1 1.00 1.00 – 321, 482 218, 391 503, 894
5–9 2.8 1.4 to 5.2 1.15 0.87 0.32 to 2.32 6.2 3.7 to 10.3 3.07 2.40 0.90 to 6.37 63.8 58.5 to 68.7 2.29 1.96 1.43 to 2.69 150, 267 161, 289 252, 453
10+ 5.4 2.9 to 9.7 2.29 1.39 0.45 to 4.18 9.9 6.5 to 14.7 5.12 3.76 1.19 to 11.8 69.6 63.9 to 74.7 2.97 2.11 1.41 to 3.13 121, 234 141, 254 202, 373
Condom used for most recent sex with most recent partner
Yes 2.8 1.5 to 5.3 1.00 1.00 – 3.4 1.6 to 7.0 1.00 1.00 – 51.6 46.9 to 56.3 1.00 1.00 – 202, 314 170, 303 330, 586
No 3.6 2.4 to 5.4 1.28 1.59 0.67 to 3.74 6.3 4.4 to 8.9 1.90 1.88 0.81 to 4.32 58.0 54.6 to 61.3 1.30 1.01 0.74 to 1.35 352, 613 328, 592 567, 1027
Concurrent partnerships in last year**
No 2.7 1.8 to 4.2 1.00 1.00 – 4.3 2.9 to 6.4 1.00 1.00 – 51.0 47.8 to 54.2 1.00 1.00 – 439, 706 361, 639 710, 1256
Yes 6.3 2.9 to 13.4 2.40 1.34 0.48 to 3.70 8.1 4.1 to 15.3 1.95 0.75 0.27 to 2.00 74.6 67.1 to 80.8 2.81 1.46 0.93 to 2.28 66, 134 78, 146 105, 196
Unknown 3.1 1.3 to 7.2 1.14 1.13 0.38 to 3.31 7.8 4.3 to 13.9 1.88 1.46 0.62 to 3.38 64.6 57.5 to 71.2 1.76 1.53 1.02 to 2.28 73, 127 76, 144 117, 226
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DISCUSSION
Principal ﬁndings
In 2010–2012, chlamydia was a common, and commonly diag-
nosed, infection among young adults in Britain. Diagnoses had
arisen following both opportunistic screening and clinically indi-
cated testing in roughly equal numbers. Living in more deprived
areas was signiﬁcantly associated with prevalent infection after
adjusting for socio-demographic and behavioural factors. The
proportion reporting chlamydia testing was generally greater
among those reporting factors associated with chlamydia.
However, substantial proportions of young adults reporting risk
factors for chlamydia had not been recently tested.
Strengths and limitations
The major strength of our study is that we used individual-level
data from a nationally representative sample. We linked behav-
ioural and biological data to examine a range of risk factors for
different outcomes within the same survey and carried out mul-
tivariable analyses incorporating socio-demographic and behav-
ioural data to minimise confounding of associations between
predictor and outcome variables. There were some limitations.
The number of participants aged under 25 limited statistical
power to explore all associations of potential interest. For
example, while recent testing was found to be higher in England
than Scotland or Wales, consistent with chlamydia screening
being offered opportunistically as part of an organised pro-
gramme, the sample size was not large enough to determine
whether factors associated with infection differed by country.
Given the relatively small absolute numbers of prevalent infec-
tions, the proportions in speciﬁc subgroups should be inter-
preted with caution. Our ﬁndings may be affected by who
agreed to take part in the survey or provide a urine sample.
Survey weights were used to minimise bias, but unmeasured
bias remains feasible. Our comparisons between risk factors
for prevalent infection and recent testing may have been
affected by the estimation of outcomes among different
denominators. We explored this further in a sensitivity analysis,
which showed no notable difference between ORs for testing
when estimated in sexually experienced participants versus
urine study participants (data not shown). A further limitation
is the accuracy of self-reporting. Detailed questions were
answered via self-completion, which we expect to have mini-
mised social desirability bias.
Chlamydia infection was measured in urine. This may have
missed some infections in women among whom vulvovaginal
swabs demonstrate marginally higher sensitivity.26 Urine sam-
pling will also have missed rectal infections, leading to under-
estimation of the total currently infected with chlamydia.
However, the impact on our ﬁndings is likely minimal as men
who have sex with men made up a small proportion of our
sample.27
Comparison to other studies/data
Estimates of chlamydia prevalence among young adults in
Natsal-3 are comparable to those from other nationally repre-
sentative surveys from Europe and high-income countries.3
Chlamydia prevalence is also similar to that reported in the pre-
vious Natsal (conducted in 1999–2001), where prevalence for
18–24 year olds was estimated at 3.0% in women and 2.7% in
men.22 Comparisons between the surveys should be made with
caution due to differences between them17 and because they
were not powered to detect a change in prevalence. Recent
testing was not associated with area-level deprivation in our
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Table 4 Percentage, unadjusted and adjusted ORs for prevalent chlamydia infection, self-reported diagnosis in the last year and self-reported testing by socio-demographic and behavioural factors
(sexually experienced 16–24 year old men)
Prevalent infection detected in urine (n=840)
Diagnosed with chlamydia in the last year (among
those tested in the last year) (n=471) Tested for chlamydia in the last year (n=1375)
Denominator (weighted,
unweighted)*
% 95% CI OR AOR† 95% CI % 95% CI OR AOR† 95% CI % 95% CI OR AOR† 95% CI Infection Diagnosis Tested
Age group
16–19 0.3% 0.1 to 1.4 1.00 1.00 – 4.7% 2.4 to 9.0 1.00 1.00 – 40.4% 35.9 to 45.1 1.00 1.00 – 234, 343 151, 226 374, 582
20–24 3.4% 2.2 to 5.2 10.6 7.54 1.37 to 41.3 6.7% 3.9 to 11.1 1.46 0.76 0.26 to 2.15 31.1% 27.8 to 34.7 0.67 0.53 0.37 to 0.73 391, 497 192, 245 629, 793
Country‡
England 1.9% 1.2 to 3.0 1.00 1.00 – 37.3% 34.3 to 40.3 1.00 1.00 – 532, 719 316, 440 859, 1181
Scotland 5.7% 2.1 to 14.3 3.13 3.16 0.78 to 12.8 22.2% 14.0 to 33.5 0.48 0.33 0.16 to 0.64 60, 72 20, 22 89, 111
Wales 1.7% 0.2 to 12.1 0.88 1.20 0.18 to 7.63 12.8% 6.9 to 22.3 0.25 0.19 0.08 to 0.40 33, 49 7, 9 55, 83
IMD quintile of LSOA of residence§
2 least deprived 1.3% 0.4 to 3.6 1.00 1.00 – 5.2% 2.5 to 10.5 1.00 1.00 – 34.5% 30.0 to 39.2 1.00 1.00 – 241, 315 127, 180 369, 509
Middle quintile 1.6% 0.6 to 4.4 1.24 1.01 0.15 to 6.68 5.0% 1.7 to 13.8 0.96 0.68 0.15 to 2.97 33.3% 27.4 to 39.9 0.95 1.04 0.70 to 1.52 114, 164 60, 86 183, 263
2 most deprived 3.4% 2.1 to 5.6 2.71 3.75 1.11 to 12.5 6.5% 3.6 to 11.4 1.26 1.06 0.42 to 2.64 35.2% 31.1 to 39.5 1.03 1.13 0.82 to 1.53 269, 361 155, 205 450, 603
Age left school¶††
17+ 1.6% 0.9 to 2.7 1.00 5.3% 3.1 to 9.0 1.00 33.6% 30.4 to 37.1 1.00 439, 568 233, 304 703, 927
16 5.0% 2.7 to 9.2 3.28 7.2% 3.6 to 13.8 1.38 37.8% 32.3 to 43.5 1.20 143, 206 87, 134 230, 334
Age at first heterosexual sex
17+ 1.0% 0.3 to 2.8 1.00 1.00 – 2.8% 0.7 to 9.9 1.00 1.00 – 25.6% 21.4 to 30.3 1.00 1.00 – 210, 245 87, 112 340, 431
16 1.5% 0.5 to 4.6 1.49 1.14 0.27 to 4.74 4.7% 1.8 to 11.8 1.75 1.14 0.24 to 5.30 33.4% 27.9 to 39.4 1.46 1.13 0.75 to 1.67 148, 205 84, 108 253, 351
<16 4.0% 2.4 to 6.5 4.18 1.65 0.55 to 4.90 7.8% 4.7 to 12.6 2.99 1.58 0.37 to 6.62 45.3% 40.7 to 49.9 2.40 1.53 1.07 to 2.19 238, 352 167, 243 376, 539
Number of sexual partners in the last year††
0 or 1 1.5% 0.7 to 3.0 1.00 3.4% 1.5 to 7.8 1.00 26.0% 22.6 to 29.7 1.00 359, 466 145, 196 568, 768
2 1.3% 0.4 to 4.2 0.86 0.9% 0.2 to 3.9 0.27 40.3% 33.2 to 47.7 1.92 123, 159 74, 99 185, 251
3–4 3.1% 1.1 to 8.5 2.16 1.5% 0.4 to 6.2 0.44 43.0% 35.5 to 50.9 2.15 70, 110 57, 83 134, 194
5+ 7.5% 3.7 to 14.6 5.47 21.2% 12.9 to 32.7 7.54 60.9% 51.8 to 69.3 4.42 67, 100 63, 89 103, 146
Number of new sexual partners in the last year
0 1.8% 0.9 to 3.8 1.00 1.00 – 5.5% 2.3 to 12.6 1.00 1.00 – 26.0% 22.0 to 30.5 1.00 1.00 – 263, 335 108, 136 416, 540
1 0.8% 0.2 to 2.5 0.42 0.33 0.05 to 2.06 4.0% 1.7 to 9.0 0.71 1.13 0.09 to 13.9 36.7% 31.8 to 41.8 1.64 1.28 0.88 to 1.85 203, 270 115, 161 323, 452
2+ 5.1% 2.9 to 8.8 2.87 0.47 0.09 to 2.45 8.0% 4.5 to 13.7 1.48 2.87 0.26 to 30.7 46.3% 40.7 to 52.0 2.45 1.06 0.67 to 1.68 152, 229 115, 170 251, 366
Number of sexual partners in the last year without a condom
0 0.3% 0.1 to 1.3 1.00 1.00 – 1.8% 0.4 to 8.4 1.00 1.00 – 27.0% 22.4 to 32.1 1.00 1.00 – 205, 248 88, 115 331, 450
1 1.7% 0.8 to 3.6 5.26 1.23 0.09 to 15.2 4.9% 2.6 to 8.9 2.75 0.78 0.19 to 3.15 34.3% 30.2 to 38.7 1.41 1.12 0.72 to 1.71 287, 396 160, 222 475, 640
2+ 6.5% 3.9 to 10.9 21.3 4.95 0.42 to 57.9 10.9% 6.0 to 19.0 6.51 0.46 0.11 to 1.83 48.8% 42.3 to 55.4 2.59 1.37 0.80 to 2.34 130, 194 95, 134 194, 281
Number of lifetime sexual partners
1–4 0.4% 0.1 to 1.5 1.00 1.00 – 1.0% 0.3 to 3.1 1.00 1.00 – 25.3% 21.8 to 29.2 1.00 1.00 – 332, 412 133, 176 524, 706
5–9 1.2% 0.3 to 4.0 3.21 1.78 0.20 to 15.5 3.8% 1.3 to 10.8 4.15 4.87 0.58 to 40.2 39.6% 33.6 to 45.9 1.93 1.50 1.01 to 2.21 141, 200 84, 123 222, 314
10+ 7.6% 4.8 to 11.7 22.6 8.69 1.21 to 62.0 12.3% 7.6 to 19.2 14.6 19.80 3.03 to 129. 49.2% 43.2 to 55.2 2.86 2.23 1.45 to 3.42 148, 224 121, 167 247, 342
Condom used for most recent sex with most recent partner
Yes 0.7% 0.2 to 2.0 1.00 1.00 – 4.3% 2.0 to 8.9 1.00 1.00 – 33.5% 29.7 to 37.6 1.00 1.00 – 301, 391 163, 221 491, 671
No 4.1% 2.6 to 6.4 6.03 3.59 0.77 to 16.6 7.4% 4.5 to 12.0 1.79 1.06 0.35 to 3.21 38.0% 33.9 to 42.4 1.22 0.97 0.70 to 1.34 283, 398 172, 237 458, 621
Concurrent partnerships in last year**
No 2.6% 1.6 to 4.2 1.00 1.00 – 6.7% 4.1 to 10.8 1.00 1.00 – 32.9% 29.6 to 36.3 1.00 1.00 – 418, 557 219, 298 676, 916
Yes 2.0% 0.7 to 5.4 0.75 0.18 0.04 to 0.71 6.5% 2.7 to 14.8 0.96 0.60 0.19 to 1.79 49.7% 41.0 to 58.4 2.02 1.52 0.92 to 2.50 82, 121 67, 92 136, 188
Unknown 1.7% 0.5 to 5.6 0.64 0.60 0.11 to 3.00 1.3% 0.3 to 5.5 0.19 0.06 0.00 to 0.71 38.5% 30.9 to 46.7 1.28 1.18 0.77 to 1.80 92, 122 52, 75 137, 193
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study. This is contrary to an analysis of data from the southeast
of England, which found higher rates of chlamydia screening in
more deprived areas in 2008.28 This difference in ﬁndings may
reﬂect the different study period, when screening coverage was
lower, or regional variation in screening patterns.
National surveillance data on chlamydia tests and diagnoses
among 15–24 year olds are available for England for the period
covered by Natsal-3. The average coverage of chlamydia testing
in England in 2010–2012 among 15–24 year olds was 40% in
women and 20% in men.14 15 This is lower than the 57% of
women and 37% of men resident in England who reported a
test in the last year in Natsal-3. Differences between denomina-
tors (all vs sexually experienced only) and age ranges (surveil-
lance data for this period use partly aggregated data and are not
available for 16–24 year olds) may partly explain these differ-
ences. Applying the proportion of 16–24 year olds with ≥1
sexual partner estimated in Natsal-3 (80%)27 to surveillance
data results in an estimated coverage per year of 51% and 25%
among sexually experienced women and men, respectively. This
is more comparable but still somewhat lower than our estimates.
This may indicate some residual bias arising from who took part
in Natsal-3. Our ﬁndings on location of last test among those
recently diagnosed are consistent with 2011 surveillance data,
where 42% of diagnoses among 15–24 year olds were reported
from GUM clinics, 15% from family planning services, 7%
from GPs, 2% from education and 33% from other/unknown
settings.14 The proportion of diagnoses from GPs was higher in
Natsal-3 (27%) than in surveillance data. This may reﬂect the
partially aggregate nature of surveillance data as a large propor-
tion of diagnoses made in other/unknown settings are likely to
be from GPs.
Implications for chlamydia control in Britain
Encouragingly, those reporting risk factors for chlamydia were
generally more likely to report having been recently tested. This
is contrary to uptake patterns often seen in public health inter-
ventions, where those in most need are often least likely to
access care.29 However, at least one-quarter of women and
around half of men reporting a risk factor associated with preva-
lent infection had not been recently tested. This presents a clear
potential for ongoing transmission of chlamydia from high risk
but untested individuals. Almost all prevalent infections in men
were among 20–24 year olds, less than a third of whom
reported recent testing. As young women tend to have slightly
older male partners,30 sexual mixing patterns by age may play a
key role in transmission.
Our ﬁndings suggest that the likelihood of having an infec-
tion diagnosed and treated varies by deprivation, as although
screening coverage was uniform by area-level deprivation, chla-
mydia prevalence was higher in those living in more deprived
areas. This raises the question as to whether efforts to expand
or intensify chlamydia screening should prioritise those living
in more deprived areas to address this potential inequality. A
high proportion of infections were found in those who had
not used a condom at last sex, and around one-ﬁfth of recent
diagnoses were made following a test prompted by a partner
having chlamydia, which emphasises the importance of
condom use and partner notiﬁcation in chlamydia prevention
and control.
Unanswered questions and future research
Increased screening and prevention efforts among individuals
living in deprived areas and those reporting risk factors for chla-
mydia who are not regularly accessing screening may reduce the
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Figure 1 Bubble plot showing unadjusted ORs for prevalent chlamydia infection compared with recent testing by socio-demographic and
behavioural factors, and proportion of prevalent infections in each group (16-year-old to 24-year-old sexually experienced women (A) and men (B)).
Factors in the upper-right-hand quadrant are those where both the odds of prevalent infection and of testing were higher than the reference group.
Factors in the upper-left-hand quadrant show those where the odds of prevalent infection were higher, but odds of testing were lower than the
reference group (for ORs, 95% CIs and denominators, see tables 3 and 4). The area of the bubble and percentage in parentheses represents the
proportion of individuals with a prevalent infection who reported the speciﬁed characteristic (for 95% CIs, see online supplementary table S1).
Letters indicate reference groups: (a) 16–19 years old; (b) resident in lower super output area in the two least deprived quintiles, as measured by
the Index of Multiple Deprivation; (c) left school at 17+ (among those aged ≥16); (d) 17+ years at ﬁrst heterosexual sex; (e) 0 or 1 sexual partners
in the last year; (f ) 0 new sexual partners in the last year; (g) 0 sexual partners in the last year without a condom; (h) 1–9 lifetime sexual partners;
(i) condom used at last sex; ( j) no concurrent partnership in last year (among those with 1+ more sexual partners in last year); (k) reports binge
drinking never or less than monthly; and (l) never had same sex contact/experience.
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prevalence of undiagnosed infection and decrease transmission.
The relative costs, feasibility and acceptability of different
approaches to chlamydia screening warrant careful consideration
in light of our ﬁndings.
Key messages
▸ Using a nationally representative sample of the British
population, we compared factors associated with chlamydia
prevalence, testing and diagnosis among 16-year-old to
24-year-old women and men.
▸ The proportion reporting chlamydia testing was generally
greater among those reporting factors associated with
chlamydia (eg, among those with more sexual partners).
▸ However, substantial proportions of young adults reporting
risk factors for chlamydia had not been recently tested.
▸ Greater screening and prevention efforts among individuals
living in deprived areas and those reporting risk factors for
chlamydia who are not regularly accessing screening may
reduce the prevalence of undiagnosed infection and
decrease transmission.
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